Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimers disease clinical trial cohort

Mild-AD subjects without significant Aβ pathology represent a confounding finding for clinical trials because they may not progress clinically on the expected trajectory, adding variance into analyses where slowing of progression is being measured.

from Dementia Big http://ift.tt/1XLUrS9
via Stopping Dementia

from WordPress http://ift.tt/248b9yX
via alcoholic dementia
http://ift.tt/1WhtJSw